This retrospective survey of healthcare professionals in France examined how often patients with suspected chronic inflammatory demyelinating polyneuropathy (CIDP) who did not respond to intravenous immunoglobulin (IVIg) were later identified as having hereditary transthyretin amyloidosis (ATTRv).
